47.69
price down icon0.02%   -0.01
 
loading

Tourmaline Bio Inc Azioni (TRML) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - -
Operating Expenses
7.34%
26.23
24.44 21.97 17.52
Operating Income/Loss
7.34%
-26.23
-24.44 -21.97 -17.52
Income/Loss From Continuing Operations Before Tax
13.84%
-22.97
-20.18 -17.49 -13.31
Income/Loss From Continuing Operations After Tax
13.84%
-22.97
-20.18 -17.49 -13.31
Net Income/Loss
13.84%
-22.97
-20.18 -17.49 -13.31
Preferred Stock Dividends And Other Adjustments
-
- - -
Attributable To Noncontrolling Interest
-
- - -
Basic Average Shares
0.29%
25.69
25.77 25.72 24.08
Diluted Average Shares
0.29%
25.69
25.77 25.72 24.08
Basic Earnings Per Share
14.10%
-0.89
-0.78 -0.68 -0.55
Diluted Earnings Per Share
14.10%
-0.89
-0.78 -0.68 -0.55
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - -
$35.73
price up icon 0.25%
$86.00
price up icon 1.42%
$28.04
price down icon 0.14%
$96.31
price down icon 1.87%
$145.86
price up icon 0.75%
biotechnology ONC
$342.89
price up icon 3.22%
Capitalizzazione:     |  Volume (24 ore):